Abstract
A retrospective analysis of patients who underwent radiofrequency ablation (RFA) of
intrahepatic cholangiocarcinoma (IHCC) was performed. Seven patients with 9 tumors
underwent RFA. The mean tumor size was 2.4 cm (range=1.3–3.3 cm). RFA achieved technique
effectiveness and local tumor control in 89% (8/9 tumors) of the patients respectively,
with a mean overall survival of 38.5 months (range=12–69 months). To conclude, RFA
was effective in achieving local tumor control and may offer a therapeutic option
for patients with recurrent or primary IHCC.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical ImagingAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Current status of intrahepatic cholangiocarcinoma.World J Gastroenterol. 2008; 14: 6287-6289
- Diagnosis and treatment of cholangiocarcinoma.Oncologist. 2004; 9: 43-57
- Treatment and outcome of intrahepatic cholangiocellular carcinoma.Am J Surg. 2005; 189: 173-177
- Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.Hepatology. 2001; 33: 1353-1357
- The epidemiology of cholangio-carcinoma.Semin Liver Dis. 2005; 24: 115-125
- Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998.Gut. 2001; 48: 816-820
- Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.Ann Surg. 2008; 248: 84-96
- Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.Ann Surg Oncol. 2009; 16: 404-412
- Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers.Chang Gung Med J. 2009; 32: 22-32
- The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.Ann Surg. 2009; 249: 20-25
- Radiofrequency ablation of liver tumors: a systematic review.Arch Surg. 2006; 141: 181-190
- Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.Eur Radiol. 2001; 11: 914-921
- Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma.World J Surg. 2005; 29: 1364-1373
- Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.Ann Surg. 2004; 240: 900-909
- Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?.Hepatology. 2004; 47: 82-89
- Society of Interventional Radiology clinical practice guidelines.J Vasc Interv Radiol. 2003; 14: 199-202
- Image-guided tumor ablation: standardization of terminology and reporting criteria.J Vasc Interv Radiol. 2009; 20: 377-390
- Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.N Engl J Med. 2010; 362: 1273-1281
- Intrahepatic cholangiocarcinoma.World J Surg. 1997; 21: 301-306
- Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection.Eur J Radiol. 2011; 80: 221-225
- Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience.Cardiovasc Intervent Radiol. 2010; 33: 835-839
- Percutaneous ultrasound guided radiofrequency ablation of intrahepatic cholangiocarcinoma.Kaohsiung J Med Sci. 2005; 21: 304-309
- Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.AJR Am J Roentgenol. 2011; 196: 205-209
- Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma.J Vasc Interv Radiol. 2012; 23: 642-649
Article info
Publication history
Published online: February 10, 2014
Accepted:
January 27,
2014
Received in revised form:
January 16,
2014
Received:
September 3,
2013
Footnotes
☆Conflict of interest: Authors declare no conflicts of interest.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
